期刊文献+
共找到25,553篇文章
< 1 2 250 >
每页显示 20 50 100
CAR-T细胞治疗产品上市前注册检验的特殊要求及关注点
1
作者 吴雪伶 许崇凤 +5 位作者 李国亚 范珊珊 贾春翠 董思国 金宇轩 孟淑芳 《中国细胞生物学学报》 2026年第1期166-173,共8页
药品上市前注册检验是我国药品监管的关键环节之一,与其他生物药相比,自体CAR-T细胞治疗产品因其自体产品特性及患者用药时效性等限制,导致其在生产工艺及质量控制等方面存在特殊性,这也使得注册检验面临诸多独特的挑战。该文系统总结... 药品上市前注册检验是我国药品监管的关键环节之一,与其他生物药相比,自体CAR-T细胞治疗产品因其自体产品特性及患者用药时效性等限制,导致其在生产工艺及质量控制等方面存在特殊性,这也使得注册检验面临诸多独特的挑战。该文系统总结了近几年已完成的自体CAR-T细胞产品注册检验的情况,深入分析了在现行法规要求下,自体CAR-T细胞注册检验在产品特性、生产工艺、样本时效及监管等方面所面临的挑战及对应的解决措施,系统梳理了在注册检验中发现的包括质量标准、方法开发与验证等方面存在的问题,深入探讨了检验前沟通的重要性、核心沟通内容,以及方法转移和确认的相关要点,旨在为研发者就该类产品的注册检验工作提供参考,推动产品的规范化上市进程。 展开更多
关键词 car-T细胞治疗产品 上市前 注册检验 特殊要求 关注点
原文传递
荷瘤小鼠单次静脉给予快速制备的BCMA CAR-T细胞毒性研究
2
作者 黄瑛 赵晓政 +5 位作者 霍桂桃 寇小旋 赵晶 赵婷婷 胡雪莲 文海若 《中国医药生物技术》 2026年第2期110-119,共10页
目的评价快速制备的Instan21B CAR-T细胞(INS21B)在荷瘤免疫缺陷小鼠体内的安全性。方法采用免疫缺陷型NPG小鼠,通过输入H929-LAE-dWF细胞构建移植瘤模型,并在此基础上给予受试物INS21B,考察小鼠中位生存时间(MST)、肿瘤细胞清除情况、... 目的评价快速制备的Instan21B CAR-T细胞(INS21B)在荷瘤免疫缺陷小鼠体内的安全性。方法采用免疫缺陷型NPG小鼠,通过输入H929-LAE-dWF细胞构建移植瘤模型,并在此基础上给予受试物INS21B,考察小鼠中位生存时间(MST)、肿瘤细胞清除情况、临床症状、体质量和摄食量变化、细胞因子、T细胞亚群分类、血液学和血清生化学指标和组织病理学变化特点。结果非荷瘤组小鼠MST大于90 d,溶媒组、T细胞组、INS21B低剂量组和INS21B高剂量组小鼠的MST分别约为40、45、90和50 d;给予INS21B后可一定程度上缓解H929-LAE-dWF细胞在荷瘤小鼠体内增殖导致的体重降低和摄食量降低,变化趋势相符;给予细胞后第9天起,INS21B低、高剂量组的平均荧光强度与T细胞组相比较低(第9天:P<0.05);Mono和Eos为重要的免疫细胞,在给予细胞后6周时Mono和Eos数量增多;INS21B可导致人源IFN-γ和TNF水平升高;给予细胞后4~6周时,低、高剂量组小鼠体内CAR^(+)T细胞数量明显增加,均在给予细胞后第6周达峰值;不同时间点,INS21B各剂量组ALT、AST、ALP、CK和LDH的平均值与溶媒组或T细胞组相比均更接近于非荷瘤组。结论INS21B在H929-LAE-dWF荷瘤NPG小鼠体内未见明显免疫毒性和相关致瘤性的风险,且呈现一定药效学作用,并对实体瘤的毒理学评价提供借鉴。 展开更多
关键词 Instan21B car-T细胞 免疫缺陷荷瘤小鼠 移植瘤 毒性研究
暂未订购
Exploration of multi-functional peptides with bioactive and flavorful properties in Inner Mongolian cheese by peptidomics and bioinformatics
3
作者 Yuqian Zheng Zhiyong Cui +8 位作者 Shengnan Wang Chengliang Qi Amin Zhang Xueqian Guo Shilong Zhao Yuan Liu Zhihai Gao Xinya Ma Wenli Wang 《Food Science and Human Wellness》 2025年第9期3461-3471,共11页
The naturally fermented Inner Mongolian cheese’s flavor and nutritional value make it a popular choice among customers.In this work,to create multi-functional peptides that have taste and biological activity,peptidom... The naturally fermented Inner Mongolian cheese’s flavor and nutritional value make it a popular choice among customers.In this work,to create multi-functional peptides that have taste and biological activity,peptidomics and bioinformatics were used to screen flavor peptides from Inner Mongolian cheese and further assess their antioxidant and angiotensin I-converting enzyme(ACE)inhibitory properties.According to sensory data,YH8 and IL7 had detectable bitter tastes with low thresholds of 0.03 and 0.06 mmol/L,respectively.With an umami threshold range of 0.24‒0.81 mmol/L,VQ6,FK13,HP13 and QT14 exhibited a range of flavors dominated by umami,including sweet,bitter,salty,sour and kokumi.Antioxidant activity wise,YH8,VQ6,HP13 and QT14 were well represented.The above-mentioned peptides all had some ACE inhibitory effect.The bitter peptide IL7(IC_(50)=0.08 mmol/L)had the highest level of ACE inhibitory activity,followed by YH8(IC_(50)=0.33 mmol/L).These multi-functional peptides,which have been assessed for bioactive and taste features in Inner Mongolian cheese,may have positive impacts on health and harmonize the cheese’s overall flavor.These results suggest that some flavor peptides produced in fermented foods might be with bioactivities while providing a basis for the exploration and application of multi-functional peptides. 展开更多
关键词 Inner Mongolian cheese multi-functional peptides Flavor peptides ANTIOXIDANTS ACE inhibitory Molecular docking
在线阅读 下载PDF
Corrigendum to“Multi-functional photonic spin Hall effect sensor controlled by phase transition”
4
作者 Jie Cheng Rui-Zhao Li +3 位作者 Cheng Cheng Ya-Lin Zhang Sheng-Li Liu Peng Dong 《Chinese Physics B》 2025年第9期671-671,共1页
Figure 6(a)in the paper[Chin.Phys.B 33074203(2024)]was incorrect due to editorial oversight.The correct figure is provided.This modification does not affect the result presented in the paper.
关键词 CORRIGENDUM photonic spin Hall effect multi-functional sensors phase transition sensing performance
原文传递
CAR-T疗法在未分化甲状腺癌中靶点探索的研究进展
5
作者 刘艳琳 白怀茜 +2 位作者 李志刚 戴晓雁 王娟 《中国药物警戒》 2026年第3期349-354,共6页
目的探讨嵌合抗原受体T细胞(Chimeric Antigen Receptor T-cell,CAR-T)疗法在未分化甲状腺癌(Anaplastic Thyroid Cancer,ATC)治疗中的靶点研究与应用进展。方法综合分析近年来国内外关于CAR-T疗法在ATC中的研究,归纳其主要靶点(如ICAM-... 目的探讨嵌合抗原受体T细胞(Chimeric Antigen Receptor T-cell,CAR-T)疗法在未分化甲状腺癌(Anaplastic Thyroid Cancer,ATC)治疗中的靶点研究与应用进展。方法综合分析近年来国内外关于CAR-T疗法在ATC中的研究,归纳其主要靶点(如ICAM-1、TSHR、CSPG4、B7-H3、ROR1等)及作用机制,并分析其临床应用中的关键问题。结果CAR-T可通过靶向多种ATC相关抗原发挥抗肿瘤作用,但治疗仍受到肿瘤异质性、免疫抑制微环境及安全风险等因素限制。结论深入开展ATC相关抗原的探索与CAR结构优化,结合联合治疗策略,有望提升CAR-T疗法的治疗效能,为ATC的精准免疫治疗提供新的方向与理论基础。 展开更多
关键词 未分化甲状腺癌 嵌合抗原受体T细胞(car-T) 免疫治疗
暂未订购
An Overview of Drag Reduction Methods in Road Cars
6
作者 Umberto Ravelli Silvia Ravelli 《Fluid Dynamics & Materials Processing》 2026年第2期1-41,共41页
Aerodynamic research on road cars was reviewed in this work under the thread of reducing drag,with the awareness that this may succeed in effectively decreasing the carbon footprint of transportation.First,a selection... Aerodynamic research on road cars was reviewed in this work under the thread of reducing drag,with the awareness that this may succeed in effectively decreasing the carbon footprint of transportation.First,a selection of studies was presented to focus on the most important aerodynamic features of the flow around realistic car body shapes.Then,the discussion was organized around three pillars related to passive flow control,active flow control and active aerodynamics.Both experimental and numerical investigations were included to provide a comprehensive overview.A clear distinction was made between simplified and realistic car models,as well as production vehicles(within the limits of restricted access information).Moreover,a short essay was dedicated to electric vehicles,for which aerodynamics matters,especially at highway speeds.Last,the impact of aerodynamic principles on the design of current and future vehicle fleet was assessed,honestly admitting that recent market trends must be reversed to turn decarbonization goals into reality and damp the effects of global warming. 展开更多
关键词 Road cars AERODYNAMICS drag coefficient passive flowcontrol active flowcontrol active aerodynamics
在线阅读 下载PDF
Breaking Through Oral Gene Delivery Barriers:Peptide Nanocarriers Delivering CAR Genes for Targeted Pancreatic Cancer Therapy
7
作者 YIN Ting 《生物化学与生物物理进展》 北大核心 2026年第2期273-274,共2页
A recently published study(Xin et al.,Prog Biochem Biophys,2026,53(2):431-441.DOI:10.3724/j.pibb.2025.0508)addresses the therapeutic challenges of pancreatic ductal adenocarcinoma(PDAC)by innovatively developing an or... A recently published study(Xin et al.,Prog Biochem Biophys,2026,53(2):431-441.DOI:10.3724/j.pibb.2025.0508)addresses the therapeutic challenges of pancreatic ductal adenocarcinoma(PDAC)by innovatively developing an orally administered nanogene delivery system.Designed to achieve in situ,efficient delivery of chimeric antigen receptor(CAR)genes to tumor sites,this approach offers a novel strategy for CAR-macrophage(CAR-M)based immunotherapy.Its key highlights are as follows. 展开更多
关键词 targeted pancreatic cancer therapy situ delivery orally administered nanogene delivery systemdesigned car genes pancreatic ductal adenocarcinoma pdac oral gene delivery chimeric antigen receptor peptide nanocarriers
原文传递
难治性系统性红斑狼疮患者CAR-T治疗的护理
8
作者 周红 邹亮 《护理学杂志》 北大核心 2026年第2期60-63,78,共5页
目的 总结6例难治性系统性红斑狼疮患者接受嵌合抗原受体T细胞(CAR-T)免疫疗法的护理经验。方法 为6例系统性红斑狼疮患者制订全流程化管理:输注前完善风险筛查,包括风险管理、基础疾病控制、感染筛查,完成细胞采集和清淋处理;输注中严... 目的 总结6例难治性系统性红斑狼疮患者接受嵌合抗原受体T细胞(CAR-T)免疫疗法的护理经验。方法 为6例系统性红斑狼疮患者制订全流程化管理:输注前完善风险筛查,包括风险管理、基础疾病控制、感染筛查,完成细胞采集和清淋处理;输注中严格遵循无菌操作规范,控制细胞输注速度,实时监测生命体征及不良反应;输注后重点落实细胞因子释放综合征、免疫效应细胞相关神经毒性综合征、血细胞减少的护理监测,并将心理护理、营养支持、健康教育贯穿治疗全过程。结果 6例患者均成功输注靶向CD19的嵌合抗原受体T细胞,且均达到预期治疗效果。5例出现Ⅰ级细胞因子释放综合征,其中4例表现为发热,5例出现全身各部位散在皮疹,4例出现四肢肌肉酸痛或乏力;6例均出现不同程度的白细胞减少,2例合并贫血和血小板减少;未观察到免疫效应细胞相关神经毒性综合征。结论 CAR-T免疫疗法治疗难治性系统性红斑狼疮具有良好疗效,但并发症多,及时护理干预是促进患者治疗顺利进行的重要保障,需覆盖治疗全周期。 展开更多
关键词 系统性红斑狼疮 嵌合抗原受体T细胞 免疫疗法 car-T 细胞因子释放综合征 神经毒性综合征 护理
暂未订购
The Therapeutic Potential of CAR γδ T Cells:From Cancer to Autoimmune Disease
9
作者 Chanu Lee Suhyun Che Jea-Hyun Baek 《BIOCELL》 2026年第2期67-92,共26页
The paradigm of cancer treatment has been reshaped by chimeric antigen receptor(CAR)αβT cell therapy,yet its full potential remains constrained by fundamental limitations.While conventional CARαβT cells have achie... The paradigm of cancer treatment has been reshaped by chimeric antigen receptor(CAR)αβT cell therapy,yet its full potential remains constrained by fundamental limitations.While conventional CARαβT cells have achieved notable success in hematological malignancies,their broader application is hindered by the high cost and delays of autologous manufacturing,as well as the critical risk of graft-vs-host disease(GvHD).In addition,their efficacy against solid tumors is often compromised by the immunosuppressive tumor microenvironment(TME).As a promising solution,γδT cells are being developed as an alternative CAR platform.Their intrinsic ability to recognize transformed cells in a major histocompatibility complex(MHC)-independent manner minimizes the risk of GvHD and supports the creation of safe,effective allogeneic therapies.Building on this unique biology,the therapeutic efficacy of CARγδT cells is being enhanced through advanced engineering strategies.Key innovations include“armoring”technologies,such as cytokine secretion,checkpoint blockade,and metabolic rewiring,to overcome local immunosuppression and improve persistence,as well as the use of induced pluripotent stem cells(iPSCs)to generate standardized products from a renewable and consistent source.This expanding technological toolbox is also enabling novel applications beyond oncology.For example,chimeric autoantibody receptor(CAAR)constructs built onγδT cells integrate both classical and emerging insights into CARγδT cell therapy,highlighting innovations that are driving the field toward safer,more versatile,and longer-lasting treatments for cancer and autoimmunity.In light of these advancements,this review provides an overview of the current understanding ofγδT cell biology and highlights emerging engineering strategies that enhance the efficacy and durability of CARγδT cells across oncologic and autoimmune contexts. 展开更多
关键词 Chimeric antigen receptor(car)T cells γδT cells cancer immunotherapy autoimmune and inflammatory disease precision medicine
暂未订购
靶向CD117的CAR-T细胞对急性髓系白血病细胞Kasumi-1的体外杀伤效应
10
作者 韩盼盼 陈绪靖 +7 位作者 陈汉祎 王淑燕 詹思建 莫胜水 陈丽丽 冯娅茹 林伟 王建勋 《中国肿瘤生物治疗杂志》 北大核心 2026年第1期45-50,共6页
目的:制备低亲和力的CD117 CAR-T细胞,探讨其对急性髓系白血病(AML)细胞Kasumi-1的体外杀伤效应。方法:调取CD117低亲和力抗体巴佐利单抗(barzolvolimab)和Fab-79D VH和VL序列,设计VH-(G4S)3-VL结构的单链抗体,分别构建带4-1BB共刺激分... 目的:制备低亲和力的CD117 CAR-T细胞,探讨其对急性髓系白血病(AML)细胞Kasumi-1的体外杀伤效应。方法:调取CD117低亲和力抗体巴佐利单抗(barzolvolimab)和Fab-79D VH和VL序列,设计VH-(G4S)3-VL结构的单链抗体,分别构建带4-1BB共刺激分子的经典二代CAR分子,经基因合成后分别亚克隆至pMFG逆转录病毒载体,获得CD117-79D CAR和CD117-0159 CAR质粒。将两种CAR质粒分别包装制备逆转录病毒,检测其滴度合格后转导活化后的T细胞,构建CD117-79D CAR-T和CD117-0159 CAR-T细胞,采用流式细胞术检测两种CAR-T细胞的阳性率。将未转导T细胞与两种CAR-T细胞分别与CD117+Kasumi-1细胞共培养,通过流式细胞术检测Kasumi-1细胞凋亡率,以评估两种CAR-T细胞的抗肿瘤活性。结果:成功构建CD117-79D CAR-T和CD117-0159 CAR-T细胞,其阳性率分别为(59.4±2.6)%、(62.5±1.2)%。未转导T细胞、CD117-79D CAR-T和CD117-0159 CAR-T细胞体外培养均能稳定增殖,且三者的增殖能力均无显著差异(均P>0.05)。体外杀伤Kasumi-1细胞结果显示,不同效靶比条件下,CD117-79D CAR-T和CD117-0159 CAR-T细胞较未转导T细胞展现出显著增强的杀伤能力(P<0.05或P<0.01),但两种CAR-T细胞的杀伤效率无显著差异(P>0.05)。结论:成功构建低亲和力的CD117-79 CAR-T和CD117-0159 CAR-T细胞,体外实验证实其可有效杀伤CD117+Kasumi-1细胞,为AML的靶向治疗提供了实验依据。 展开更多
关键词 CD117抗原 嵌合抗原受体 T淋巴细胞 单链抗体 免疫治疗
原文传递
CAR-T细胞的生产与质控
11
作者 石琳 王永增 吕璐璐 《中国细胞生物学学报》 2026年第1期195-207,共13页
嵌合抗原受体T细胞(CAR-T)是一种新型的免疫细胞疗法,近几年在血液肿瘤治疗中取得了显著成效,同时在自身免疫性疾病以及实体肿瘤领域也取得了突破性进展。CAR-T细胞产品制备工艺复杂,其生产与质控流程的规范对保障治疗安全性与有效性至... 嵌合抗原受体T细胞(CAR-T)是一种新型的免疫细胞疗法,近几年在血液肿瘤治疗中取得了显著成效,同时在自身免疫性疾病以及实体肿瘤领域也取得了突破性进展。CAR-T细胞产品制备工艺复杂,其生产与质控流程的规范对保障治疗安全性与有效性至关重要。该文详细阐述了CAR-T细胞产品的生产工艺以及质量控制各环节需要充分考虑的技术要点与关键控制项目,包括生产物料、生产模式、生产设备和生产工艺,以及某些质量控制项目。此外,该文结合临床应用实践的经验,展望了未来CAR-T细胞产品技术发展路径和检测方法开发方向,旨为CAR-T细胞治疗领域从业同仁提供参考,共同推动该领域规范化发展。 展开更多
关键词 car-T细胞 细胞治疗 生产工艺 质量控制
原文传递
CAR-T细胞治疗在多发性骨髓瘤中的应用
12
作者 刘洋 李振宇 《中国生物化学与分子生物学报》 北大核心 2026年第1期46-53,共8页
多发性骨髓瘤(multiple myeloma,MM)是一种不可治愈的血液系统恶性肿瘤,尽管新型蛋白酶体抑制剂、免疫调节剂及CD38单抗等药物的应用显著延长了患者的生存时间,但复发耐药仍难以避免。细胞免疫治疗,特别是嵌合抗原受体(chimeric antigen... 多发性骨髓瘤(multiple myeloma,MM)是一种不可治愈的血液系统恶性肿瘤,尽管新型蛋白酶体抑制剂、免疫调节剂及CD38单抗等药物的应用显著延长了患者的生存时间,但复发耐药仍难以避免。细胞免疫治疗,特别是嵌合抗原受体(chimeric antigen receptor,CAR)T细胞疗法的快速发展,极大程度的改变了复发/难治性(relapsed/refractory,R/R)MM患者的治疗现状。FDA目前已批准了2款靶向B细胞成熟抗原(B cell maturation antigen,BCMA)的CAR-T细胞产品,使其用于既往接受过4线及以上治疗的R/R MM患者。随着临床研究的不断深入,靶向GPRC5D(G protein-coupled receptor C class Group 5 member D,G蛋白偶联受体C类第5组成员D)的CAR-T细胞治疗也显示出其独特的优势。除了应用于难治复发的患者,多项临床试验支持CAR-T在MM中治疗线数的前移。本文就CAR-T细胞治疗在MM中开展的关键性临床研究展开综述,旨在为临床应用提供参考。 展开更多
关键词 多发性骨髓瘤 嵌合抗原受体T细胞 B细胞成熟抗原 G蛋白偶联受体C类第5组成员D
原文传递
CAR-T细胞治疗的临床关键问题和对策 被引量:3
13
作者 陈新峰 刘莎莎 张毅 《中国肿瘤生物治疗杂志》 北大核心 2025年第1期9-13,共5页
自2017年以来,已有12款嵌合抗原受体基因修饰T淋巴细胞(CAR-T细胞)产品相继被批准用于血液系统恶性肿瘤的治疗,包括复发性/难治性急性B淋巴细胞白血病、特定亚型B细胞淋巴瘤和多发性骨髓瘤。然而,CAR-T细胞疗法在应用过程中面临诸多挑战... 自2017年以来,已有12款嵌合抗原受体基因修饰T淋巴细胞(CAR-T细胞)产品相继被批准用于血液系统恶性肿瘤的治疗,包括复发性/难治性急性B淋巴细胞白血病、特定亚型B细胞淋巴瘤和多发性骨髓瘤。然而,CAR-T细胞疗法在应用过程中面临诸多挑战,如在治疗血液系统肿瘤中的抵抗、生产周期长、个体化/价格昂贵,在实体瘤中的肿瘤异质性强/抗原逃逸、浸润能力不足、免疫抑制微环境和反应性差等问题。随着肿瘤免疫学研究的深入和基因工程技术的发展,尝试了众多新策略来提升CAR-T细胞疗法的疗效和普适性。作者根据自身对该领域研究的认知,针对CAR-T细胞疗法的临床关键问题及其应对解决策略进行述评,为未来CAR-T细胞疗法的基础研究和临床转化提供重要思路。 展开更多
关键词 免疫治疗 嵌合抗原受体基因修饰T淋巴细胞 肿瘤微环境 实体瘤
原文传递
Multi-functional SiC/Al Composites for Aerospace Applications 被引量:74
14
作者 Cui Yan Wang Lifeng Ren Jianyue 《Chinese Journal of Aeronautics》 SCIE EI CAS CSCD 2008年第6期578-584,共7页
Multi-functional Al-matrix composites with high volume fraction (55%-57%) of SiC particles are produced with the new pressureless infiltration fabrication technology. X-ray detection and microscopic observation disp... Multi-functional Al-matrix composites with high volume fraction (55%-57%) of SiC particles are produced with the new pressureless infiltration fabrication technology. X-ray detection and microscopic observation display the composites which are macroscopically homogeneous without porosity. The investigation further reveals that the SiC/Al composites possess low density (2.94 g/cm^3), high elastic modulus (220 GPa), prominent thermal management function as a result of low coefficient of thermal expansion (8 × 10^4 K^-1) and high thermal conductivity (235 W/(m.K)) as well as unique preventability of resonance vibration. By adopting a series of developed techniques, the multi-functional SiC/Al composites have managed to be made into near-net-shape parts. Many kinds of precision components of space-based optomechanical structures and airborne optoelectronic platform have been turned out. Of them, several typical products are being under test in practices. 展开更多
关键词 COMPOSITES multi-function INFILTRATION SIC ALUMINUM aerospace applications
原文传递
Multi-functional sites catalysts based on post-synthetic modification of metal-organic frameworks 被引量:7
15
作者 Dingxuan Ma Baiyan Li Zhan Shi 《Chinese Chemical Letters》 SCIE CAS CSCD 2018年第6期827-830,共4页
Metal-organic frameworks(MOFs) are a unique class of porous crystalline materials that have shown promise for a wide range of applications. MOFs have been explored as a new type of heterogeneous catalytic materials,... Metal-organic frameworks(MOFs) are a unique class of porous crystalline materials that have shown promise for a wide range of applications. MOFs have been explored as a new type of heterogeneous catalytic materials, because of their high surface area, uniform and tunable pores, facile functionalization and incorporation of catalytic active sites. The use of multi-functional sites MOF materials as catalysts for synergistic catalysis and tandem reactions has attracted increasing attention. In this review, we aim to introduce the construction of bi-or multi-functional MOF catalysts with cooperative or cascade functions via post-synthetic modification(PSM). 展开更多
关键词 Metal-organic frameworks multi-functional sites CATALYSIS Post-synthetic modification
原文传递
CAR-T细胞治疗研发态势分析
16
作者 高倩 曹文娟 江洪 《中国生物工程杂志》 北大核心 2025年第12期114-122,共9页
嵌合抗原受体T(chimeric antigen receptor T,CAR-T)细胞治疗通过基因修饰T细胞使其能够靶向并杀伤异常细胞,已在血液系统恶性肿瘤治疗中取得显著成效,成为肿瘤免疫治疗发展的重要里程碑,并迅速发展成为生物制药领域的热点赛道。基于科... 嵌合抗原受体T(chimeric antigen receptor T,CAR-T)细胞治疗通过基因修饰T细胞使其能够靶向并杀伤异常细胞,已在血液系统恶性肿瘤治疗中取得显著成效,成为肿瘤免疫治疗发展的重要里程碑,并迅速发展成为生物制药领域的热点赛道。基于科技文献计量分析发现,全球CAR-T治疗基础研究持续活跃,其中美国和中国处于领先地位。通过VOSviewer的知识图谱分析显示,中国与美国、德国、英国等在CAR-T细胞治疗基础研究方面建立了紧密的合作网络;当前研究热点主要聚焦于核心技术与基础研究、疗效提升、肿瘤中的临床应用以及非肿瘤中的新兴应用四大方向。未来该领域的研究重点集中在技术创新、个性化医疗和国际合作三个方面。 展开更多
关键词 car-T细胞治疗 科技文献计量 知识图谱分析
原文传递
外周血NLR、CAR、SF水平在评估小儿肺炎支原体肺炎病情严重程度及预后中的临床价值 被引量:4
17
作者 郭宏丽 刘奇 +2 位作者 李诚 王红艳 李凯歌 《转化医学杂志》 2025年第1期10-14,41,共6页
目的 分析外周血中性粒细胞/淋巴细胞(NLR)、C反应蛋白/白蛋白比率(CAR)、铁蛋白(SF)水平在评估小儿肺炎支原体肺炎(MPP)病情严重程度及预后中的临床价值。方法 回顾性分析2021年1月至2024年3月西安交通大学附属红会医院儿科收治的104例... 目的 分析外周血中性粒细胞/淋巴细胞(NLR)、C反应蛋白/白蛋白比率(CAR)、铁蛋白(SF)水平在评估小儿肺炎支原体肺炎(MPP)病情严重程度及预后中的临床价值。方法 回顾性分析2021年1月至2024年3月西安交通大学附属红会医院儿科收治的104例MPP患儿的临床资料,并纳入MPP组,另选取同期体检健康儿童63名为健康对照组,比较2组外周血NLR、CAR、SF水平。依据临床肺部感染评分(CPIS)将MPP患儿分为轻症组(n=56)、中重症组(n=48),比较轻症组与中重症组的外周血NLR、CAR、SF水平和急性生理学与慢性健康状况Ⅱ(APACHEⅡ)评分。通过Pearson相关性分析外周血NLR、CAR、SF水平与APACHEⅡ评分相关性;以疗效判定标准分为预后不良组(n=69)和预后良好组(n=35),比较2组上述指标的变化,并绘制受试者工作特征(ROC)曲线分析外周血NLR、CAR、SF水平分别诊断及联合预测MPP患儿预后不良的诊断效能。结果 MPP组的外周血NLR、CAR、SF水平高于健康对照组,差异有统计学意义(P <0.05);中重症组的外周血NLR、CAR、SF水平和APACHEⅡ评分均高于轻症组,差异有统计学意义(P <0.05);预后不良组的外周血NLR、CAR、SF水平和APACHEⅡ评分均高于预后良好组,差异有统计学意义(P <0.05);经Pearson相关性分析显示,MPP患儿外周血NLR、CAR、SF水平与APACHEⅡ评分呈正相关(r=0.813、0.798、0.808,P <0.001);对外周血NLR、CAR、SF相对表达水平及三者联合诊断因子做ROC曲线分析,曲线下面积(AUC)分别为0.882、0.883、0.854及0.897,预测MPP患儿预后的敏感度分别为82.86%、80.00%、77.14%及85.71%,特异度分别为92.75%、92.75%、94.20%及91.30%。结论 MPP患儿外周血NLR、CAR、SF水平明显高于健康儿童,且随着病情加重上述指标水平提高,与病情严重程度呈正相关性,三者联合预测MPP患儿预后不良的诊断效能高。 展开更多
关键词 外周血NLR 外周血car 外周血SF
暂未订购
BCMA-CD19双靶点CAR-T细胞治疗在狼疮性肾炎中的长期疗效及安全性评估
18
作者 何善智 丁菱 +12 位作者 王俊贤 王敏 王明霞 邹婵娟 颜丝语 陈润杰 陆子骥 郭子文 叶晴 黄桂英 王伟佳 梁颖文 袁润强 《中华临床免疫和变态反应杂志》 2025年第6期397-405,共9页
目的评估BCMA-CD19双靶点嵌合抗原受体T细胞(CAR-T)治疗在狼疮性肾炎(LN)患者中的长期疗效与安全性。方法回顾性分析11例接受BCMA-CD19双靶点CAR-T细胞治疗的狼疮肾炎患者,中位随访30(30,33)个月,评估临床缓解率;对其中9例进行了重复肾... 目的评估BCMA-CD19双靶点嵌合抗原受体T细胞(CAR-T)治疗在狼疮性肾炎(LN)患者中的长期疗效与安全性。方法回顾性分析11例接受BCMA-CD19双靶点CAR-T细胞治疗的狼疮肾炎患者,中位随访30(30,33)个月,评估临床缓解率;对其中9例进行了重复肾活检的患者评估病理改变、活动指数(AI)和慢性指数(CI)变化趋势。结果CAR-T细胞治疗后6个月,SLEDAI评分平均下降9.18分(P<0.001);11例(100%)达到低疾病活动度(LLDAS),其中6例(63.6%)达到系统性红斑狼疮缓解(DORIS);治疗后6个月、12个月、24个月及30个月间缓解情况比较,差异无统计学意义。重复肾活检显示免疫荧光强度降低,AI显著下降[ΔAI=(-1.67±0.52),P=0.01],CI呈升高趋势但差异无统计学意义(P=0.067)。所有患者随访期间未出现结核感染、肝炎病毒感染或恶性肿瘤。结论BCMA-CD19双靶点CAR-T细胞治疗可在长达3年的随访中持续诱导难治性LN患者临床缓解,显著降低肾脏病理活动度,且安全性良好;但仍需开展更长时间以及更大样本量研究予以验证其长期疗效及机制。 展开更多
关键词 狼疮性肾炎 系统性红斑狼疮 BCMA CD19 car-T
暂未订购
Design of Drilling and Riveting Multi-functional End Effector for CFRP and Aluminum Components in Robotic Aircraft Assembly 被引量:6
19
作者 Zhang Lin Tian Wei +4 位作者 Li Dawei Hong Peng Li Zhenyu Zhou Weixue Liao Wenhe 《Transactions of Nanjing University of Aeronautics and Astronautics》 EI CSCD 2018年第3期529-538,共10页
To fulfill the demands for higher quality,efficiency and flexibility in aviation industry,a multi-functional end effector is designed to automate the drilling and riveting processes in assembling carbon fiber reinforc... To fulfill the demands for higher quality,efficiency and flexibility in aviation industry,a multi-functional end effector is designed to automate the drilling and riveting processes in assembling carbon fiber reinforced polymer(CFRP)and aluminum components for a robotic aircraft assembly system.To meet the specific functional requirements for blind rivet installation on CFRP and aluminum materials,additional modules are incorporated on the end effector aside of the basic processing modules for drilling.And all of these processing modules allow for a onestep-drilling-countersinking process,hole inspection,automatic rivet feed,rivet geometry check,sealant application,rivet insertion and installation.Besides,to guarantee the better quality of the hole drilled and joints riveted,several online detection and adjustment measures are applied to this end effector,including the reference detection and perpendicular calibration,which could effectively ensure the positioning precision and perpendicular accuracy as demanded.Finally,the test result shows that this end effector is capable of producing each hole to a positioning precision within ±0.5 mm,aperpendicular accuracy within 0.3°,a diameter tolerance of H8,and a countersink depth tolerance of±0.01 mm.Moreover,it could drill and rivet up to three joints per minute,with acceptable shearing and tensile strength. 展开更多
关键词 robotic aircraft assembly CFRP and aluminum components automatic drilling and riveting multi-functional end effector online detection and adjustment
在线阅读 下载PDF
Development of a novel multi-functional integrated bioconjugate effectively targeting K-Ras mutant pancreatic cancer 被引量:1
20
作者 Yang-Yang Wang Liang Li +4 位作者 Xiu-Jun Liu Qing-Fang Miao Yi Li Meng-Ran Zhang Yong-Su Zhen 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2022年第2期232-242,共11页
Folate receptor(FR)overexpression occurs in a variety of cancers,including pancreatic cancer.In addition,enhanced macropinocytosis exists in K-Ras mutant pancreatic cancer.Furthermore,the occurrence of intensive desmo... Folate receptor(FR)overexpression occurs in a variety of cancers,including pancreatic cancer.In addition,enhanced macropinocytosis exists in K-Ras mutant pancreatic cancer.Furthermore,the occurrence of intensive desmoplasia causes a hypoxic microenvironment in pancreatic cancer.In this study,a novel FR-directed,macropinocytosis-enhanced,and highly cytotoxic bioconjugate folate(F)-human serum albumin(HSA)-apoprotein of lidamycin(LDP)-active enediyne(AE)derived from lidamycin was designed and prepared.F-HSA-LDP-AE consisted of four moieties:F,HSA,LDP,and AE.F-HSA-LDP presented high binding efficiency with the FR and pancreatic cancer cells.Its uptake in wild-type cells was more extensive than in K-Ras mutant-type cells.By in vivo optical imaging,F-HSA-LDP displayed prominent tumor-specific biodistribution in pancreatic cancer xenograft-bearing mice,showing clear and lasting tumor localization for 360 h.In the MTT assay,F-HSA-LDP-AE demonstrated potent cytotoxicity in three types of pancreatic cancer cell lines.It also induced apoptosis and caused G2/M cell cycle arrest.F-HSALDP-AE markedly suppressed the tumor growth of AsPc-1 pancreatic cancer xenografts in athymic mice.At well-tolerated doses of 0.5 and 1 mg/kg,(i.v.,twice),the inhibition rates were 91.2%and 94.8%,respectively(P<0.01).The results of this study indicate that the F-HSA-LDP multi-functional bioconjugate might be effective for treating K-Ras mutant pancreatic cancer. 展开更多
关键词 Pancreatic cancer Folate receptor multi-functional Macropinocytosis-enhanced BIOCONJUGATE K-RAS PEGYLATION
暂未订购
上一页 1 2 250 下一页 到第
使用帮助 返回顶部